Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
Nucleic acid and genetic medicines are increasingly being developed, owing to their potential to treat a variety of intractable diseases. A comprehensive understanding of the in vivo fate of these agents is vital for the rational design, discovery, and fast and straightforward development of the dru...
Main Authors: | Shintaro Fumoto, Tsuyoshi Yamamoto, Kazuya Okami, Yuina Maemura, Chisato Terada, Asako Yamayoshi, Koyo Nishida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/159 |
Similar Items
-
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
by: Fumito Wada, et al.
Published: (2021-12-01) -
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
by: Chisato Terada, et al.
Published: (2022-11-01) -
Liposome-mediated transfection /
by: 347843 Whitt, Michael, et al. -
Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
by: Yu Mikame, et al.
Published: (2023-10-01) -
Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice
by: Naoki Yoshikawa, et al.
Published: (2020-04-01)